Related Links

» submit an item · an event

Professor Barry Potter
Professor Barry Potter
Synthetic Bath drug candidate crystallized in target protein active site
Synthetic Bath drug candidate crystallized in target protein active site

Internal News - 28 September 2006

Professor joins Wellcome Trust Funding Board

In recognition of his research standing in the fields of chemical biology and medicinal chemistry, Professor Barry Potter, Department of Pharmacy & Pharmacology, has been invited to join the Wellcome Trust Molecules Genes and Cells funding board.

Professor Potter said: “I’m delighted to be invited to join this key Wellcome Trust panel, which is responsible for funding and funding strategy of basic biomedical research across the UK and internationally.”

The Wellcome Trust is an independent charity funding research to improve human and animal health. Established in 1936 and with an endowment of around £11 billion, it is the UK's largest non-governmental source of funds for biomedical research.

Professor Potter has been Head of Medicinal Chemistry at the University since 1991. His fields of research activity are at the interfaces between chemistry, biology and medicine, in particular concerning cellular signalling molecules and anticancer drug design. Compounds designed in the group at Bath have already reached multiple clinical trials.

The appointment runs for three years.

Professor Potter’s work at the University is currently supported by a £1 million programme grant from the Wellcome Trust, a Wellcome Trust biomedical research collaboration grant with the University of Hamburg, as well as grants from industry.